TNDM Q1 2021 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$141M+44.0% YoY

Gross Profit

$73M52.0% margin

Operating Income

-$3M-2.3% margin

Net Income

-$5M-3.6% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-16.1%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$25M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$754M

Total Liabilities

$441M

Stockholders' Equity

$313M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$141M	$98M	+44.0%
Gross Profit	$73M	$50M	+45.8%
Operating Income	-$3M	-$14M	+76.2%
Net Income	-$5M	-$15M	+66.1%

Geographic Segments

UNITED STATES

$103M73%

Non-US

$38M27%